| 书目名称 | Tumor Therapeutic Regimens and Comprehensive Evaluation | | 副标题 | A comprehensive eval | | 编辑 | Qiu Li,Xiao-Shi Zhang | | 视频video | http://file.papertrans.cn/931/930833/930833.mp4 | | 概述 | Comprehensively and systematically evaluates the treatment programs for malignant tumors.The evaluation indicators are converted into numerical values.Includes multiple indicators such as clinical ben | | 图书封面 |  | | 描述 | This book starts from the clinical reality, take practicality as the purpose, closely integrate clinical work, including important clinical therapeutic regimens for various cancer, and describes the new developments in treatment of common malignant tumors. At the same time, in combination with improved version of the ASCO value framework, systematic and standardized comparisons and in-depth evaluations of therapeutic regimens were made to promote the standardization of medical treatment decisions for malignant tumors..Compared with the traditional evaluation method of malignant tumor therapeutic regimens, the evaluation method of this book has outstanding advantages. First, the evaluation indicators are comprehensive and diverse. The evaluation includes multiple indicators such as clinical benefits, adverse reactions, additional benefits, and costs, and includes more effective evaluation indicators to comprehensively evaluate the treatment plan. Second, the evaluation indicators are converted into numerical values, and different indicators are effectively quantified to make the result evaluation easier and more objective...This book systematically and comprehensively reflects the h | | 出版日期 | Book 2023 | | 关键词 | medical oncology; ASCO evaluation guidelines; therapy comparison and decision-making; clinical trial; Qu | | 版次 | 1 | | doi | https://doi.org/10.1007/978-981-99-1421-0 | | isbn_softcover | 978-981-99-1423-4 | | isbn_ebook | 978-981-99-1421-0 | | copyright | People‘s Medical Publishing House, PR of China 2023 |
The information of publication is updating
|
|
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-8-5 09:37
发表于 2025-3-21 17:23:12
